Last reviewed · How we verify
Observational Study on the Effects of DRSP-Containing Combined Oral Contraceptives (Yasmin,Yasminelle) and Other Combined Oral Contraceptives on the General and Sexual Well-Being in COC Users (COSME)
The purpose of this study is to evaluate the symptoms and satisfaction for women taking drospirenone (DRSP)-containing combined oral contraceptives in comparison with women taking other kind of combined oral contraceptives.
Details
| Lead sponsor | Bayer |
|---|---|
| Status | COMPLETED |
| Enrolment | 632 |
| Start date | 2008-01 |
| Completion | 2010-12 |
Conditions
- Contraception
Interventions
- EE30-DRSP (Yasmin, BAY86-5131)
- Other combined oral contraceptives
Primary outcomes
- Psychophysical well-being evaluated by the Psychological General Well-Being Index (PGWBI) — at 12 months
- Sexual well-being evaluated by the Female Sexual Function Index (FSFI) — at 12 months
Countries
Italy